Based on short-term price targets offered by four analysts, the average price target for Cara Therapeutics comes to $ The forecasts range from a low of. CARA Forecast/Price Target · Average $ · Low $ · High $ Get Cara Therapeutics Inc (CARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. CARA's current price target is $ Learn why top analysts are making this stock forecast for Cara Therapeutics at MarketBeat. Find the latest analyst research, reports, and ratings for Cara Therapeutics, Inc. Common Stock (CARA) at Nasdaq stock price targets. Analysts.
It currently costs $ to buy one share in Cara Therapeutics Inc. (as of 02/08/ ) which is a change of or % from the last closing price. The 2 analysts with month price forecasts for Cara Therapeutics stock have an average target of , which predicts an increase of % from the current. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. Cara Therapeutics Inc is currently in a favorable trading position (BUY) according to technical analysis indicators. More on Technical Analysis. Peers. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Cara Therapeutics to be priced at by the end of this quarter and at. The current price of CARA is USD — it has increased by % in the past 24 hours. Watch Cara Therapeutics, Inc. stock price performance more closely on. For the upcoming trading day on Monday, 16th we expect Cara Therapeutics to open at $, and during the day (based on 14 day Average True Range), to move. Access real-time $Cara Therapeutics stock insights on eToro. ➤ View prices, charts, and analyst price target ✓ Invest in CARA Now. (NASDAQ: CARA) Cara Therapeutics currently has 54,, outstanding shares. With Cara Therapeutics stock trading at $ per share, the total value of Cara. The CARA Therapeutics stock prediction for is currently $ , assuming that CARA Therapeutics shares will continue growing at the average yearly rate. Cara Therapeutics is forecast to grow earnings and revenue by % and % per annum respectively while EPS is expected to grow by 36% per annum. Future.
Cara Therapeutics, Inc. (CARA) stock forecast and price target · CARACara Therapeutics, Inc. (%). At close: June 17 Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing. Cara Therapeutics (CARA) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary. On average, Wall Street analysts predict that Cara Therapeutics's share price could reach $ by Jun 13, The average Cara Therapeutics stock price. What is the Cara Therapeutics stock price / share price today? The Cara Therapeutics stock price is USD today. Will CARA stock price drop / fall? Yes. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CARA will report earnings. According to analysts, CARA price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Cara Therapeutics Inc has a consensus price target of $ based on the ratings of 9 analysts. The high is $28 issued by Stifel on June 27,
View Cara Therapeutics (CARA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with. View Cara Therapeutics Inc CARA stock quote prices, financial information, real-time forecasts, and company news from CNN. The stock price for Cara Therapeutics (NASDAQ: CARA) is $ last updated September 16, at AM EDT. Q. Does Cara Therapeutics (CARA). Consensus Cara Therapeutics, Inc. Equities. CARA. US Market Closed - Nasdaq. Other stock markets. Is Cara Therapeutics Stock Undervalued? The current Cara Therapeutics [CARA] share price is $ The Score for CARA is 10, which is 80% below its historic.
Cara Therapeutics Inc has a share price target of US$ 2, revenue growth forecast of %, and profit growth estimate of % for FY24, based on top 5. Analyst. Target Price. · 5 analysts ; Earnings. EPS Forecast. Up. Next quarter ; Investor. New Investor. Acuitas Investments, LLC. +% Portfolio. Price-To-Sales vs Industry: CARA is good value based on its Price-To-Sales Ratio (x) compared to the US Pharmaceuticals industry average (x). Stock Price Statistics The stock price has decreased by % in the last 52 weeks. The beta is , so CARA's price volatility has been lower than the. Analyst. Target Price. USD. 5 analysts ; Investor. Trend. Sold. % shares ; Trading. Volume. Average. x.